We combine FDA-approved GLP-1 medications, InBody® 970 body composition technology, and expert medical supervision to help you reach your goals safely.
15–22%
Average weight loss
$45
To start
$145
Per month
Save 75%
vs. retail pharmacy
We have removed the complexity from medical weight loss. Here is what to expect.
Meet in-person with our medical team. We review your medical history, current health status, and weight loss goals.
We go beyond the scale. Using hospital-grade technology, we analyze your muscle mass, water weight, and visceral fat to create a true baseline.
If eligible, you receive your FDA-approved GLP-1 medication (Mounjaro®, Zepbound®, Wegovy®, or Ozempic®) the same day. No pharmacy lines.
Unlimited follow-ups, weekly dietitian webinars, body composition tracking, dose optimization, and loyalty rewards that grow over time.
Most clinics rely on BMI, which is outdated and inaccurate. Premier Weight Loss utilizes the InBody 970, the most advanced body composition analyzer available.
This allows us to ensure you are losing fat, not muscle. Preserving lean muscle mass is critical for keeping your metabolism high and maintaining weight loss long-term.
60s
Scan time
98%
Clinical accuracy
50+
Metrics tracked
Final candidacy is determined by your provider during your initial visit. The lists below cover the most common screening criteria.
No insurance needed. Brand-name medications prescribed directly from our Indianapolis clinics. Cancel anytime.
* Off-label divided dosing
* Off-label divided dosing
$145/mo after your first month, unlimited everything except medication, which is sold separately.
15–17%
Avg loss with semaglutide
Wegovy / Ozempic, 68 wk
20–22%
Avg loss with tirzepatide
Mounjaro / Zepbound, 72 wk
Up to 75%
Cheaper than retail
Direct-prescribing model
1 Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989, 1002.
2 Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205, 216.
We exclusively prescribe brand-name GLP-1 agonists. We never use compounded or generic alternatives.
Tirzepatide
20–22%
Avg loss
$275/mo
Starting
FDA-approved for type 2 diabetes but widely prescribed off-label for weight loss due to its powerful tirzepatide formula.
Learn more →Tirzepatide
20–22%
Avg loss
$275/mo
Starting
Received FDA approval in November 2023 as a groundbreaking treatment for chronic weight management.
Learn more →Semaglutide
15–17%
Avg loss
$175/mo
Starting
The first GLP-1 medication FDA-approved specifically for weight loss in adults with obesity.
Learn more →Semaglutide
14–15%
Avg loss
$175/mo
Starting
Made headlines as the medication that introduced millions to the power of GLP-1 therapy.
Learn more →★★★★★ 5.0 Google rating across both Indianapolis locations.
★★★★★
“I lost 35 pounds in six months. The team made it feel easy, no shame, no judgement. The in-clinic medication pickup was a huge plus. Transparent pricing too, no surprises.”
Sarah M.
Verified Google Review · Fishers
★★★★★
“I was skeptical of weight loss programs after trying everything. Premier was different from day one. The provider listened, the InBody scans showed real progress beyond the scale, and the price was honest. Worth every penny.”
Jason R.
Verified Google Review · Carmel
★★★★★
“My GLP-1 medication ships to my door each month and the dietitian webinars keep me on track. Direct prescribing saves me hundreds vs the pharmacy. I have my confidence back.”
Amanda L.
Verified Google Review · Noblesville
Common questions about our weight loss program.
We exclusively prescribe brand-name FDA-approved GLP-1 medications: Mounjaro (tirzepatide), Zepbound (tirzepatide), Wegovy (semaglutide), and Ozempic (semaglutide). We never use compounded or generic alternatives. All medications are prescribed directly from our clinic.
Clinical trials show patients can lose 15 to 22% of their body weight with GLP-1 medications. Tirzepatide (Mounjaro/Zepbound) has shown up to 22% weight loss, while semaglutide (Wegovy/Ozempic) shows up to 15%. Individual results vary based on starting weight, medication, and adherence to the program.
The InBody 970 is a hospital-grade body composition analyzer with 98% clinical accuracy. In 60 seconds, it measures muscle mass, body fat percentage, water weight, and visceral fat, far more useful than BMI alone. This ensures you are losing fat, not muscle, which is critical for maintaining long-term results.
First month membership is $45 (includes assessment, InBody scan, and consultation). Ongoing membership is $145/month for unlimited appointments, scans, and coaching. Medication costs are separate: Ozempic starts at $175/month, Zepbound at $275/month. No insurance needed. Cancel anytime.
We recommend an initial in-person visit for your consultation and first InBody scan. After that, many follow-up appointments can be conducted via telehealth. We have clinics in Indianapolis (North Indy) and Fishers (Crosspoint), and telehealth is available statewide in Indiana.
No. We do not bill insurance. Our direct-prescribing model eliminates the middleman, allowing us to offer brand-name GLP-1 medications at up to 75% below retail pharmacy prices. We accept cash, credit/debit cards, and HSA/FSA cards.
Reserve your initial consultation. $45 secures your spot and applies in full to your first visit. Same-week availability for both in-person and virtual.
